HomeAI · summaries
Storia in 3 fonti
Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn
Lupin acquires 82.2% stake in Kaveri Therapeutics, licensing two oncology assets for $1.6 million to enhance clinical trials.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
- ·
thehindubusinessline.com
Lupin spins out two cancer drug programmes to new US venture for $1.6 million stake
Lupin licenses two cancer drug programs to Kaveri Therapeutics for an $1.6 million stake, enhancing its oncology portfolio.
